Connecticut HB05225 prohibits manufacturers, wholesalers, pharmacists, and prescribing practitioners from knowingly selling, dispensing.
Connecticut HB05225 amends state statutes to prohibit manufacturers, wholesalers, pharmacists, and prescribing practitioners from knowingly selling, dispensing, transferring, or delivering drugs or devices intended for use in executing a death sentence. The bill also includes provisions for the regulation of sterile compounding pharmacies, including reporting requirements for violations and noncompliance with environmental sampling testing. Additionally, it outlines penalties for violations, including fines and imprisonment. The act is set to take effect on October 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.